48 results
Page 2 of 3
8-K
EX-99.1
yg64oiairn8qfskc kb
17 Dec 13
Provectus Announces Name Change to Provectus Biopharmaceuticals, Inc. and Reincorporates in Delaware
12:00am
8-K
EX-99.1
bhbj9qrvnrcnqb4ind2
13 Sep 13
Regulation FD Disclosure
12:00am
424B3
ernhza6oil1v7rgqa8t
16 Apr 13
Prospectus supplement
12:00am
8-K
EX-99.1
idsh lpp62qdo3nd35
17 Oct 12
Regulation FD Disclosure
12:00am
8-K
EX-99.1
5dy0l0hqhksha3q8j
14 May 12
Departure of Directors or Certain Officers
12:00am
8-K
EX-99.1
bawey0 6rhdylzior
20 Dec 11
Provectus Pharmaceuticals, Inc. and Its Subsidiaries Complete Unregistered Offering of Units to Facilitate Spin-off of Pure-ific Corporation
12:00am
8-K
EX-99.1
j8lx6bpf7i8lzd
19 Sep 11
Offering of Units In Anticipation of Previously Announced Spin-off of the Subsidiaries
12:00am
8-K
EX-99.2
r8ylhuphh ac
13 Jul 11
Stuart Fuchs Joins Provectus Pharmaceuticals’s
12:00am
8-K
EX-99.1
6suypf
13 Jul 11
Stuart Fuchs Joins Provectus Pharmaceuticals’s
12:00am
8-K
EX-99.1
qpv2o6z a02bv6
1 Mar 11
Regulation FD Disclosure
12:00am
8-K
EX-99.1
6mzxc lb2q
13 Jan 11
Provectus Pharmaceuticals, Inc. Announces Registered Direct Offering of Common Stock and Warrants In Aggregate Amount of $5.1 Million
12:00am
424B3
qpjhg961et5ava
5 Apr 10
Prospectus supplement
12:00am
8-K
EX-99.1
ga8zpync0
12 Mar 10
Provectus Pharmaceuticals Executes Purchase Agreements
12:00am
8-K
EX-99.2
o7khnezb8rvx0zih7qam
12 Mar 10
Provectus Pharmaceuticals Executes Purchase Agreements
12:00am
10-K
94rcnzu8ra626a6jk
31 Mar 09
Annual report
12:00am